Nikolaos Tselis
Frankfurt Am Main, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 77 publications
High-dose-rate monotherapy for localised prostate Cancer: A two-implant approach with median 13 years follow-up.
Journal: Clinical and translational radiation oncology
Published: May 08, 2026
HDR Mould-Based Brachytherapy for Cutaneous Neoplasms: Toxicity, Long-Term Control, Cosmesis and PROMs.
Journal: Dermatology and therapy
Published: August 02, 2025
Influence of PSA level at salvage radiotherapy on metastasis-free survival following radical prostatectomy.
Journal: World journal of urology
Published: May 21, 2025
Radical Prostatectomy Versus Radiation Therapy for Locally Advanced and Clinically Nodal Positive Prostate Cancer.
Journal: Clinical genitourinary cancer
Published: March 14, 2025
ACO/ARO/AIO-22 - External beam radiotherapy combined with endorectal high-dose-rate brachytherapy in elderly and frail patients with rectal cancer: A prospective multicentre trial of the German Rectal Cancer Study Group.
Journal: Clinical and translational radiation oncology
Published: January 22, 2025
Validity of High-Dose-Rate Interstitial Brachytherapy as Monotherapy for Mobile Tongue Cancer in Terms of the Acute Mucosal Reaction.
Journal: The Kurume medical journal
Published: November 27, 2024
Real world comparison of adjuvant vs. salvage radiation therapy on cancer-control outcomes after radical prostatectomy.
Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Published: November 05, 2024
Radical Prostatectomy Versus Radiotherapy for Prostate Cancer: Stage-, Age-, and Frailty-Specific Cancer-Control Outcomes of 2600 Patients.
Journal: Deutsches Arzteblatt international
Published: October 19, 2024
Advantages of 3D printed patient-individual moulds in brachytherapy for facial skin cancer.
Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Published: July 01, 2024
Real-world evidence of outcomes of oligometastatic hormone-sensitive prostate cancer patients treated with metastasis-directed therapy.
Journal: The Prostate
Published: June 25, 2023
Last Updated: 09/26/2026